ID GLN1B_MYCBO Reviewed; 478 AA. AC P0A591; A0A1R3Y0L0; Q10377; X2BKH2; DT 15-MAR-2005, integrated into UniProtKB/Swiss-Prot. DT 15-MAR-2005, sequence version 1. DT 27-MAR-2024, entry version 104. DE RecName: Full=Glutamine synthetase {ECO:0000303|PubMed:24112767}; DE Short=GS {ECO:0000303|PubMed:24112767}; DE EC=6.3.1.2 {ECO:0000305|PubMed:24112767}; DE AltName: Full=Glutamate--ammonia ligase {ECO:0000250|UniProtKB:P9WN39}; DE AltName: Full=Glutamine synthetase I beta {ECO:0000250|UniProtKB:P9WN39}; DE Short=GSI beta {ECO:0000250|UniProtKB:P9WN39}; GN Name=glnA1 {ECO:0000303|PubMed:24112767}; Synonyms=glnA; GN OrderedLocusNames=BQ2027_MB2244; OS Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97). OC Bacteria; Actinomycetota; Actinomycetes; Mycobacteriales; Mycobacteriaceae; OC Mycobacterium; Mycobacterium tuberculosis complex. OX NCBI_TaxID=233413; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=BCG; RA Suh C.-I., Sung H.-C.; RT "Glutamine synthetase structural gene (glnA) Mycobacterium bovis BCG."; RL Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC BAA-935 / AF2122/97; RX PubMed=12788972; DOI=10.1073/pnas.1130426100; RA Garnier T., Eiglmeier K., Camus J.-C., Medina N., Mansoor H., Pryor M., RA Duthoy S., Grondin S., Lacroix C., Monsempe C., Simon S., Harris B., RA Atkin R., Doggett J., Mayes R., Keating L., Wheeler P.R., Parkhill J., RA Barrell B.G., Cole S.T., Gordon S.V., Hewinson R.G.; RT "The complete genome sequence of Mycobacterium bovis."; RL Proc. Natl. Acad. Sci. U.S.A. 100:7877-7882(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND GENOME REANNOTATION. RC STRAIN=ATCC BAA-935 / AF2122/97; RX PubMed=28385856; DOI=10.1128/genomea.00157-17; RA Malone K.M., Farrell D., Stuber T.P., Schubert O.T., Aebersold R., RA Robbe-Austerman S., Gordon S.V.; RT "Updated reference genome sequence and annotation of Mycobacterium bovis RT AF2122/97."; RL Genome Announc. 5:E00157-E00157(2017). RN [4] RP ACTIVITY REGULATION. RC STRAIN=ATCC 27294 / H37Rv; RX PubMed=15037612; DOI=10.1074/jbc.m401652200; RA Mehta R., Pearson J.T., Mahajan S., Nath A., Hickey M.J., Sherman D.R., RA Atkins W.M.; RT "Adenylylation and catalytic properties of Mycobacterium tuberculosis RT glutamine synthetase expressed in Escherichia coli versus mycobacteria."; RL J. Biol. Chem. 279:22477-22482(2004). RN [5] RP FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=24112767; DOI=10.1186/1471-2180-13-226; RA Tripathi D., Chandra H., Bhatnagar R.; RT "Poly-L-glutamate/glutamine synthesis in the cell wall of Mycobacterium RT bovis is regulated in response to nitrogen availability."; RL BMC Microbiol. 13:226-226(2013). CC -!- FUNCTION: Involved in nitrogen metabolism via ammonium assimilation CC (PubMed:24112767). Catalyzes the ATP-dependent biosynthesis of CC glutamine from glutamate and ammonia (PubMed:24112767). Also plays a CC key role in controlling the ammonia levels within infected host cells CC and so contributes to the pathogens capacity to inhibit phagosome CC acidification and phagosome-lysosome fusion (By similarity). Involved CC in cell wall biosynthesis via the production of the major component CC poly-L-glutamine (PLG) (PubMed:24112767). PLG synthesis in the cell CC wall occurs only in nitrogen limiting conditions and on the contrary CC high nitrogen conditions inhibit PLG synthesis (PubMed:24112767). CC {ECO:0000250|UniProtKB:P9WN39, ECO:0000269|PubMed:24112767}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-glutamate + NH4(+) = ADP + H(+) + L-glutamine + CC phosphate; Xref=Rhea:RHEA:16169, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:28938, ChEBI:CHEBI:29985, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:58359, ChEBI:CHEBI:456216; EC=6.3.1.2; CC Evidence={ECO:0000305|PubMed:24112767}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000250|UniProtKB:P9WN39}; CC Note=Binds 2 Mg(2+) ions per subunit. {ECO:0000250|UniProtKB:P9WN39}; CC -!- ACTIVITY REGULATION: When cellular nitrogen levels are high, the C- CC terminal adenylyl transferase (AT) of GlnE inhibits GlnA by covalent CC transfer of an adenylyl group from ATP to Tyr-406 (PubMed:15037612). CC Conversely, when nitrogen levels are low, the N-terminal adenylyl CC removase (AR) of GlnE activates GlnA by removing the adenylyl group by CC phosphorolysis (PubMed:15037612). The fully adenylated enzyme complex CC is inactive (Probable). {ECO:0000269|PubMed:15037612}. CC -!- SUBUNIT: Oligomer of 12 subunits arranged in the form of two hexagons. CC {ECO:0000250|UniProtKB:P9WN39}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P9WN39}. CC -!- SIMILARITY: Belongs to the glutamine synthetase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF458290; AAL58468.1; -; Genomic_DNA. DR EMBL; LT708304; SIU00852.1; -; Genomic_DNA. DR RefSeq; NP_855893.1; NC_002945.3. DR RefSeq; WP_003411475.1; NC_002945.4. DR AlphaFoldDB; P0A591; -. DR SMR; P0A591; -. DR GeneID; 45426197; -. DR PATRIC; fig|233413.5.peg.2460; -. DR BRENDA; 6.3.1.2; 3494. DR Proteomes; UP000001419; Chromosome. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0004356; F:glutamine synthetase activity; IEA:UniProtKB-EC. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0006542; P:glutamine biosynthetic process; IEA:InterPro. DR Gene3D; 3.10.20.70; Glutamine synthetase, N-terminal domain; 1. DR Gene3D; 3.30.590.10; Glutamine synthetase/guanido kinase, catalytic domain; 1. DR InterPro; IPR008147; Gln_synt_N. DR InterPro; IPR036651; Gln_synt_N_sf. DR InterPro; IPR014746; Gln_synth/guanido_kin_cat_dom. DR InterPro; IPR008146; Gln_synth_cat_dom. DR InterPro; IPR027303; Gln_synth_gly_rich_site. DR InterPro; IPR004809; Gln_synth_I. DR InterPro; IPR001637; Gln_synth_I_adenylation_site. DR InterPro; IPR027302; Gln_synth_N_conserv_site. DR NCBIfam; TIGR00653; GlnA; 1. DR PANTHER; PTHR43407; GLUTAMINE SYNTHETASE; 1. DR PANTHER; PTHR43407:SF1; LENGSIN; 1. DR Pfam; PF00120; Gln-synt_C; 1. DR Pfam; PF03951; Gln-synt_N; 1. DR SMART; SM01230; Gln-synt_C; 1. DR SUPFAM; SSF54368; Glutamine synthetase, N-terminal domain; 1. DR SUPFAM; SSF55931; Glutamine synthetase/guanido kinase; 1. DR PROSITE; PS00180; GLNA_1; 1. DR PROSITE; PS00182; GLNA_ADENYLATION; 1. DR PROSITE; PS00181; GLNA_ATP; 1. DR PROSITE; PS51986; GS_BETA_GRASP; 1. DR PROSITE; PS51987; GS_CATALYTIC; 1. PE 1: Evidence at protein level; KW ATP-binding; Cytoplasm; Ligase; Magnesium; Metal-binding; KW Nucleotide-binding; Phosphoprotein; Reference proteome; Virulence. FT CHAIN 1..478 FT /note="Glutamine synthetase" FT /id="PRO_0000153244" FT DOMAIN 16..100 FT /note="GS beta-grasp" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01330" FT DOMAIN 108..478 FT /note="GS catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01331" FT BINDING 133 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 135 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 214 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 219 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 227 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 230..232 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 271..272 FT /ligand="L-glutamate" FT /ligand_id="ChEBI:CHEBI:29985" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 272 FT /ligand="L-glutamate" FT /ligand_id="ChEBI:CHEBI:29985" FT /evidence="ECO:0000250|UniProtKB:P12425" FT BINDING 276 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 278..280 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 280 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P77961" FT BINDING 329 FT /ligand="L-glutamate" FT /ligand_id="ChEBI:CHEBI:29985" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 335 FT /ligand="L-glutamate" FT /ligand_id="ChEBI:CHEBI:29985" FT /evidence="ECO:0000250|UniProtKB:P0A1P6" FT BINDING 347 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 347 FT /ligand="L-glutamate" FT /ligand_id="ChEBI:CHEBI:29985" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 352 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 361 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P77961" FT BINDING 366 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT BINDING 368 FT /ligand="L-glutamate" FT /ligand_id="ChEBI:CHEBI:29985" FT /evidence="ECO:0000250|UniProtKB:P9WN39" FT MOD_RES 406 FT /note="O-AMP-tyrosine" FT /evidence="ECO:0000250|UniProtKB:P9WN39" SQ SEQUENCE 478 AA; 53570 MW; 576E30073484136D CRC64; MTEKTPDDVF KLAKDEKVEY VDVRFCDLPG IMQHFTIPAS AFDKSVFDDG LAFDGSSIRG FQSIHESDML LLPDPETARI DPFRAAKTLN INFFVHDPFT LEPYSRDPRN IARKAENYLI STGIADTAYF GAEAEFYIFD SVSFDSRANG SFYEVDAISG WWNTGAATEA DGSPNRGYKV RHKGGYFPVA PNDQYVDLRD KMLTNLINSG FILEKGHHEV GSGGQAEINY QFNSLLHAAD DMQLYKYIIK NTAWQNGKTV TFMPKPLFGD NGSGMHCHQS LWKDGAPLMY DETGYAGLSD TARHYIGGLL HHAPSLLAFT NPTVNSYKRL VPGYEAPINL VYSQRNRSAC VRIPITGSNP KAKRLEFRSP DSSGNPYLAF SAMLMAGLDG IKNKIEPQAP VDKDLYELPP EEAASIPQTP TQLSDVIDRL EADHEYLTEG GVFTNDLIET WISFKRENEI EPVNIRPHPY EFALYYDV //